[1P-846_1SP-10-14] Understanding of epigenomes during medulloblastoma formation identifies a novel potential therapeutic target Fosl2

^○Maho Jingu^1,2, Wanchen Wang^1,6, Kohei Kumegawa³, Ryo Shiraishi^1,7, Owen Chapman⁴, Mikio Hoshino¹, Masaki Sone², Lukas Chavez⁴, Reo Maruyama^3,5, Daisuke Kawauchi¹ (1.Dept. of Biochem. and Cell. Biol., NCNP, Tokyo, Japan, 2.Grad. Sch. of Sci., Toho Univ., Funabashi, Japan, 3.Cancer Cell Diversity Project, NEXT-Ganken Program, JFCR, Tokyo, Japan, 4.Dept. of Med., UCSD, La Jolla, California, 5.Project for Cancer Epigenomics, Cancer Inst., JFCR, Tokyo, Japan, 6.Grad. Sch. of Med. and Dent. Sci., TMDU, Tokyo, Japan, 7.JSPS Research Fellowship for Young Scientists, Post doctoral Fellow)